CIK 0001620463 · Non-accelerated filer<br>Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 453368487
- Phone
- (425) 620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 85 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-03 | Renninger Robert SVP, Finance and Accounting | Grant or award · Stock Option (Right to Buy) | +73,350 | 73,350 | ||
| 2025-03-03 | Renninger Robert SVP, Finance and Accounting | Grant or award · Stock Option (Right to Buy) | +58,500 | 58,500 | ||
| 2025-03-03 | Renninger Robert SVP, Finance and Accounting | Grant or award · Stock Option (Right to Buy) | +73,350 | 73,350 | ||
| 2025-03-03 | Renninger Robert SVP, Finance and Accounting | Grant or award · Restricted Stock Units | +39,000 | 39,000 | ||
| 2025-03-03 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +87,845 | 87,845 | ||
| 2025-03-03 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award · Restricted Stock Units | +58,563 | 58,563 | ||
| 2025-03-03 | Litton Mark James President and CEO | Grant or award · Stock Option (Right to Buy) | +333,815 | 333,815 | ||
| 2025-03-03 | Litton Mark James President and CEO | Grant or award · Restricted Stock Units | +222,543 | 222,543 | ||
| 2025-03-03 | San Martin Javier CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +111,270 | 111,270 | ||
| 2025-03-03 | San Martin Javier CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +74,180 | 74,180 | ||
| 2025-03-03 | Worthington Mark General Counsel and CCO | Grant or award · Stock Option (Right to Buy) | +85,895 | 85,895 | ||
| 2025-03-03 | Worthington Mark General Counsel and CCO | Grant or award · Restricted Stock Units | +57,263 | 57,263 | ||
| 2025-01-02 | San Martin Javier CHIEF MEDICAL OFFICER | Sale | −10,826 | $0.56 | $6K | 35,841 |
| 2025-01-02 | Litton Mark James President and CEO | Sale | −25,107 | $0.56 | $14K | 242,591 |
| 2025-01-02 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sale | −8,510 | $0.56 | $5K | 130,761 |
| 2025-01-02 | Renninger Robert VP of Finance | Sale | −2,881 | $0.56 | $2K | 89,724 |
| 2025-01-02 | Worthington Mark General Counsel and CCO | Sale | −8,510 | $0.56 | $5K | 83,735 |
| 2024-12-31 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise | +46,667 | 46,667 | ||
| 2024-12-31 | San Martin Javier CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −46,667 | 93,333 | ||
| 2024-12-31 | Litton Mark James President and CEO | Option exercise | +108,333 | 267,698 |
Page 6 of 10 · 187 trades